These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 17635141

  • 1. Unravelling the mechanisms underpinning chemokine receptor activation and blockade by small molecules: a fine line between agonism and antagonism?
    Wise E, Pease JE.
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):755-9. PubMed ID: 17635141
    [Abstract] [Full Text] [Related]

  • 2. Chemokine-receptor interactions: GPCRs, glycosaminoglycans and viral chemokine binding proteins.
    Lau EK, Allen S, Hsu AR, Handel TM.
    Adv Protein Chem; 2004 Aug; 68():351-91. PubMed ID: 15500866
    [Abstract] [Full Text] [Related]

  • 3. Chapter 8. Activation mechanisms of chemokine receptors.
    Jensen PC, Rosenkilde MM.
    Methods Enzymol; 2009 Aug; 461():171-90. PubMed ID: 19480919
    [Abstract] [Full Text] [Related]

  • 4. An apparent paradox: chemokine receptor agonists can be used for anti-inflammatory therapy.
    Ali S, O'Boyle G, Mellor P, Kirby JA.
    Mol Immunol; 2007 Mar; 44(7):1477-82. PubMed ID: 17000001
    [Abstract] [Full Text] [Related]

  • 5. Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases.
    Elsner J, Escher SE, Forssmann U.
    Allergy; 2004 Dec; 59(12):1243-58. PubMed ID: 15507091
    [Abstract] [Full Text] [Related]

  • 6. Chemokine receptors: attractive targets for drug discovery.
    Godessart N.
    Ann N Y Acad Sci; 2005 Jun; 1051():647-57. PubMed ID: 16127005
    [Abstract] [Full Text] [Related]

  • 7. Chapter 12. The use of receptor homology modeling to facilitate the design of selective chemokine receptor antagonists.
    Carter PH, Tebben AJ.
    Methods Enzymol; 2009 Jun; 461():249-79. PubMed ID: 19480923
    [Abstract] [Full Text] [Related]

  • 8. The clinical potential of chemokine receptor antagonists.
    Ribeiro S, Horuk R.
    Pharmacol Ther; 2005 Jul; 107(1):44-58. PubMed ID: 15894378
    [Abstract] [Full Text] [Related]

  • 9. Targeting cellular adhesion molecules, chemokines and chemokine receptors in rheumatoid arthritis.
    Haringman JJ, Oostendorp RL, Tak PP.
    Expert Opin Emerg Drugs; 2005 May; 10(2):299-310. PubMed ID: 15934868
    [Abstract] [Full Text] [Related]

  • 10. Developing chemokine mutants with improved proteoglycan affinity and knocked-out GPCR activity as anti-inflammatory recombinant drugs.
    Potzinger H, Geretti E, Brandner B, Wabitsch V, Piccinini AM, Rek A, Kungl AJ.
    Biochem Soc Trans; 2006 Jun; 34(Pt 3):435-7. PubMed ID: 16709180
    [Abstract] [Full Text] [Related]

  • 11. Identification of CXCR3 receptor agonists in combinatorial small-molecule libraries.
    Stroke IL, Cole AG, Simhadri S, Brescia MR, Desai M, Zhang JJ, Merritt JR, Appell KC, Henderson I, Webb ML.
    Biochem Biophys Res Commun; 2006 Oct 13; 349(1):221-8. PubMed ID: 16930533
    [Abstract] [Full Text] [Related]

  • 12. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5.
    Andrews G, Jones C, Wreggett KA.
    Mol Pharmacol; 2008 Mar 13; 73(3):855-67. PubMed ID: 18042736
    [Abstract] [Full Text] [Related]

  • 13. Chemokine blockers--therapeutics in the making?
    Wells TN, Power CA, Shaw JP, Proudfoot AE.
    Trends Pharmacol Sci; 2006 Jan 13; 27(1):41-7. PubMed ID: 16310864
    [Abstract] [Full Text] [Related]

  • 14. The synthesis of substituted bipiperidine amide compounds as CCR3 ligands: antagonists versus agonists.
    Ting PC, Umland SP, Aslanian R, Cao J, Garlisi CG, Huang Y, Jakway J, Liu Z, Shah H, Tian F, Wan Y, Shih NY.
    Bioorg Med Chem Lett; 2005 Jun 15; 15(12):3020-3. PubMed ID: 15908209
    [Abstract] [Full Text] [Related]

  • 15. Chemokines and their receptors in allergic disease.
    Pease JE, Williams TJ.
    J Allergy Clin Immunol; 2006 Aug 15; 118(2):305-18; quiz 319-20. PubMed ID: 16890751
    [Abstract] [Full Text] [Related]

  • 16. Overview of the mechanisms regulating chemokine activity and availability.
    Mortier A, Van Damme J, Proost P.
    Immunol Lett; 2012 Jul 30; 145(1-2):2-9. PubMed ID: 22698177
    [Abstract] [Full Text] [Related]

  • 17. International union of pharmacology. XXII. Nomenclature for chemokine receptors.
    Murphy PM, Baggiolini M, Charo IF, Hébert CA, Horuk R, Matsushima K, Miller LH, Oppenheim JJ, Power CA.
    Pharmacol Rev; 2000 Mar 30; 52(1):145-76. PubMed ID: 10699158
    [Abstract] [Full Text] [Related]

  • 18. Regulation of chemokine activity by posttranslational modification.
    Mortier A, Van Damme J, Proost P.
    Pharmacol Ther; 2008 Nov 30; 120(2):197-217. PubMed ID: 18793669
    [Abstract] [Full Text] [Related]

  • 19. Chemokine: receptor structure, interactions, and antagonism.
    Allen SJ, Crown SE, Handel TM.
    Annu Rev Immunol; 2007 Nov 30; 25():787-820. PubMed ID: 17291188
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis, and progress toward optimization of potent small molecule antagonists of CC chemokine receptor 8 (CCR8).
    Ghosh S, Elder A, Guo J, Mani U, Patane M, Carson K, Ye Q, Bennett R, Chi S, Jenkins T, Guan B, Kolbeck R, Smith S, Zhang C, LaRosa G, Jaffee B, Yang H, Eddy P, Lu C, Uttamsingh V, Horlick R, Harriman G, Flynn D.
    J Med Chem; 2006 May 04; 49(9):2669-72. PubMed ID: 16640325
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.